| Literature DB >> 35625909 |
Ádám Tiszlavicz1, Imre Gombos1, Mária Péter1, Zoltán Hegedűs2,3, Ákos Hunya1, Barbara Dukic1, István Nagy2,4, Begüm Peksel1, Gábor Balogh1, Ibolya Horváth1, László Vígh1, Zsolt Török1.
Abstract
Mild stress could help cells to survive more severe environmental or pathophysiological conditions. In the current study, we investigated the cellular mechanisms which contribute to the development of stress tolerance upon a prolonged (0-12 h) fever-like (40 °C) or a moderate (42.5 °C) hyperthermia in mammalian Chinese Hamster Ovary (CHO) cells. Our results indicate that mild heat triggers a distinct, dose-dependent remodeling of the cellular lipidome followed by the expression of heat shock proteins only at higher heat dosages. A significant elevation in the relative concentration of saturated membrane lipid species and specific lysophosphatidylinositol and sphingolipid species suggests prompt membrane microdomain reorganization and an overall membrane rigidification in response to the fluidizing heat in a time-dependent manner. RNAseq experiments reveal that mild heat initiates endoplasmic reticulum stress-related signaling cascades resulting in lipid rearrangement and ultimately in an elevated resistance against membrane fluidization by benzyl alcohol. To protect cells against lethal, protein-denaturing high temperatures, the classical heat shock protein response was required. The different layers of stress response elicited by different heat dosages highlight the capability of cells to utilize multiple tools to gain resistance against or to survive lethal stress conditions.Entities:
Keywords: Chinese hamster ovary cells; acquired stress tolerance; heat shock response; lipidomics; membrane; membrane lipid metabolism; stress; transcriptomics; unfolded protein response
Year: 2022 PMID: 35625909 PMCID: PMC9138356 DOI: 10.3390/biomedicines10051172
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Figure 1The effect of heat dosage on Hsp induction measured by Western blotting. (a,b) Time-dependent induction of Hsp25 upon mild heat treatment of CHO cells. Samples (40 °C and 42.5 °C denoted by black circles and red squares, respectively) were collected (a) right after (empty marks) HS or (b) following a 6 h recovery at 37 °C (solid marks). (c) Blot images of Hsp25, Hsp70 and GAPDH protein levels following a heat priming at 40 °C for 1 h or 6 h and 42.5 °C for 1 h without or with 6 h recovery (R) at 37 °C. (d) Relative quantification for Hsp25 induction in bar chart, in which recovery is indicated by checkerboard pattern. All data represent the means ± SD; n ≥ 5, p < 0.05 was considered statistically significant. Paired t-test was used for statistical comparisons, in which *, ° and + denote significant difference compared to 37 °C; 40 °C, 1 h with recovery; or 40 °C, 6 h with recovery, respectively. See experimental setup and blot images in Supplementary Figures S1 and S2.
Figure 2Acquired stress tolerance of heat-primed CHO cells. The quantitative analysis is based on colony formation assay. Primings were 1, 6 h at 40 °C or 42.5 °C for 1 h without or with 6 h recovery (R/checkerboard pattern) at 37 °C, which was followed by (a) a heat challenge with 46 °C for 20 min, (b) membrane fluidizing challenge by 95 mM BA for 20 min or (c) oxidative challenge by 250 µM TBHP for 3 h. Survival is represented as fold change compared to non-primed controls (37 °C). All data represent the means ± SD; n ≥ 3, p < 0.05 was considered statistically significant. Non-paired t-test was used for statistical comparisons, in which * denotes significant difference compared to 37 °C samples that received heat or BA challenge. See experimental setup and colony formation assay images in Supplementary Figure S4.
Figure 3The effect of heat priming on mitochondrial membrane potential and lipid peroxidation of CHO cells. (a) Change in mitochondrial membrane potential measured by fluorescent JC-1 dye. Cells were primed at 40 °C for 1 h and 42.5 °C for 1 h, then fluorescence was read before (empty bars) and after (solid bars) addition of a challenging dose of 95 mM BA. Fold change was calculated in comparison to non-treated 37 °C. (b) CHO cells were primed at 40 °C for 1 h and 6 h and at 42.5 °C for 1 h, followed by lipid peroxidation-sensitive DPPP fluorescence measurement (empty bars). After heat pretreatments a challenging dose of 95 mM BA was introduced to the cells (solid bars). In (a,b), all data represent the means ± SD; n ≥ 9, p < 0.05 was considered statistically significant. Paired t-test was used for statistical comparisons. In (a), * and ° denote statistically significant difference compared to 37 °C and 37 °C + BA, respectively, while in (b), significant difference was compared to 37 °C + BA and denoted by *.
The mouse orthologs of the top 20 most increased (red) and decreased (green) genes exhibiting statistically significant expression change (fold change > 1.5, FDR < 0.05) *. The complete dataset with the original Chinese hamster genes is listed in Table S1.
| ( | |||
|
|
|
|
|
| HSPA1A/HSPA1B | heat shock protein family A (Hsp70) member 1A | 9.82 | 0.00 × 100 |
| GLYATL3 | glycine-N-acyltransferase like 3 | 4.65 | 7.30 × 103 |
| ZFAND2A | zinc finger AN1-type containing 2A | 3.29 | 0.00 × 100 |
| DNAJB1 | DnaJ heat shock protein family (Hsp40) member B1 | 3.17 | 0.00 × 100 |
| IL11 | interleukin 11 | 2.41 | 9.05 × 10−9 |
| CLK1 | CDC like kinase 1 | 2.35 | 0.00 × 100 |
| HSPB1 | heat shock protein family B (small) member 1 | 2.35 | 9.02 × 10−12 |
| HSPH1 | heat shock protein family H (Hsp110) member 1 | 2.23 | 2.18 × 10−8 |
| JUN | Jun proto-oncogene, AP-1 transcription factor subunit | 2.09 | 0.00 × 100 |
| IER5L | immediate early response 5 like | 2.08 | 3.18 × 10−12 |
| RSRP1 | arginine and serine rich protein 1 | 2.03 | 0.00 × 100 |
| RBAK | RB associated KRAB zinc finger | 1.86 | 6.28 × 10−7 |
| BAG3 | BCL2 associated athanogene 3 | 1.84 | 4.00 × 10−8 |
| DEDD2 | death effector domain containing 2 | 1.83 | 9.10 × 10−7 |
| CEP295NL | CEP295 N-terminal like | 1.77 | 1.83 × 10−4 |
| HSPA8 | heat shock protein family A (Hsp70) member 8 | 1.65 | 6.05 × 10−10 |
| TIPARP | TCDD inducible poly(ADP-ribose) polymerase | 1.63 | 3.27 × 10−9 |
| DUSP8 | dual specificity phosphatase 8 | 1.61 | 1.10 × 10−7 |
| NUAK2 | NUAK family kinase 2 | 1.60 | 1.00 × 10−2 |
| CCDC117 | coiled-coil domain containing 117 | 1.58 | 1.73 × 10−5 |
| RIN2 | Ras and Rab interactor 2 | −309.83 | 4.55 × 10−9 |
| HOXB3 | homeobox B3 | −2.33 | 5.07 × 10−3 |
| LCMT2 | leucine carboxyl methyltransferase 2 | −2.30 | 1.39 × 10−4 |
| NAA20 | N(alpha)-acetyltransferase 20, NatB catalytic subunit | −2.13 | 8.40 × 10−3 |
| PLK2 | polo like kinase 2 | −1.90 | 0.00 × 100 |
| PTP4A1 | protein tyrosine phosphatase 4A1 | −1.73 | 4.00 × 10−2 |
| MARCHF7 | membrane associated ring-CH-type finger 7 | −1.66 | 2.68 × 10−9 |
| GAS8 | growth arrest specific 8 | −1.58 | 4.63 × 10−3 |
| FDXACB1 | ferredoxin-fold anticodon binding domain containing 1 | −1.52 | 9.58 × 10−3 |
| ( | |||
|
|
|
|
|
| CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 187.36 | 2.00 × 10−2 |
| CEL | carboxyl ester lipase | 13.19 | 4.00 × 10−2 |
| DNAH10 | dynein axonemal heavy chain 10 | 8.81 | 2.00 × 10−2 |
| GLYATL3 | glycine-N-acyltransferase like 3 | 7.06 | 5.88 × 10−6 |
| CCDC154 | coiled-coil domain containing 154 | 7.04 | 1.04 × 10−3 |
| WDR66 | WD repeat domain 66 | 6.16 | 4.99 × 10−6 |
| HSPA1A/HSPA1B | heat shock protein family A (Hsp70) member 1A | 5.50 | 1.05 × 10−13 |
| ARHGEF25 | Rho guanine nucleotide exchange factor 25 | 4.85 | 2.00 × 10−2 |
| PTP4A1 | protein tyrosine phosphatase 4A1 | 4.81 | 5.93 × 10−3 |
| COL24A1 | collagen type XXIV alpha 1 chain | 4.69 | 5.00 × 10−2 |
| SPEF1 | sperm flagellar 1 | 4.50 | 9.98 × 10−3 |
| HHIPL2 | HHIP like 2 | 4.19 | 3.53 × 10−6 |
| TNFRSF25 | TNF receptor superfamily member 25 | 3.77 | 1.00 × 10−2 |
| MTMR7 | myotubularin related protein 7 | 3.24 | 3.76 × 10−4 |
| HSPB1 | heat shock protein family B (small) member 1 | 3.05 | 0.00 × 100 |
| RGL3 | ral guanine nucleotide dissociation stimulator like 3 | 3.04 | 1.00 × 10−2 |
| RHBDL1 | rhomboid like 1 | 2.94 | 1.00 × 10−2 |
| HDAC9 | histone deacetylase 9 | 2.92 | 8.08 × 10−5 |
| TMED6 | transmembrane p24 trafficking protein 6 | 2.89 | 3.00 × 10−2 |
| ANKRD13D | ankyrin repeat domain 13D | 2.87 | 3.01 × 10−3 |
| RIN2 | Ras and Rab interactor 2 | −42.68 | 6.65 × 10−6 |
| IYD | iodotyrosine deiodinase | −8.96 | 6.90 × 10−3 |
| NAA20 | N(alpha)-acetyltransferase 20, NatB catalytic subunit | −5.69 | 1.33 × 10−12 |
| THEMIS2 | thymocyte selection associated family member 2 | −5.08 | 3.00 × 10−2 |
| FNDC10 | fibronectin type III domain containing 10 | −4.07 | 8.76 × 10−4 |
| TENM3 | teneurin transmembrane protein 3 | −3.66 | 4.01 × 10−4 |
| SDCBP2 | syndecan binding protein 2 | −3.60 | 7.06 × 10−3 |
| Ccdc74a | coiled-coil domain containing 74A | −3.14 | 4.00 × 10−2 |
| CAPN8 | calpain 8 | −3.11 | 2.45 × 10−5 |
| Dnajb3 | DnaJ heat shock protein family (Hsp40) member B3 | −2.98 | 1.98 × 10−4 |
| Gm1110 | predicted gene 1110 | −2.98 | 2.35 × 10−4 |
| Ccl2 | chemokine (C-C motif) ligand 2 | −2.97 | 0.00 × 100 |
| Ccl7 | chemokine (C-C motif) ligand 7 | −2.95 | 5.68 × 10−11 |
| EGR1 | early growth response 1 | −2.88 | 0.00 × 100 |
| EGR3 | early growth response 3 | −2.82 | 0.00 × 100 |
| CST6 | cystatin E/M | −2.78 | 4.00 × 10−2 |
| CXCL10 | C-X-C motif chemokine ligand 10 | −2.74 | 3.00 × 10−2 |
| CCR7 | C-C motif chemokine receptor 7 | −2.67 | 0.00 × 100 |
| HNRNPDL | heterogeneous nuclear ribonucleoprotein D like | −2.63 | 0.00 × 100 |
| BCLAF1 | BCL2 associated transcription factor 1 | −2.53 | 5.19 × 10−3 |
| ( | |||
|
|
|
|
|
| HSPA1A/HSPA1B | heat shock protein family A (Hsp70) member 1A | 464.60 | 0.00 × 100 |
| CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 182.50 | 1.00 × 10−2 |
| GAB2 | GRB2 associated binding protein 2 | 93.26 | 4.00 × 10−2 |
| KDF1 | keratinocyte differentiation factor 1 | 58.54 | 4.73 × 10−5 |
| AKAP5 | A-kinase anchoring protein 5 | 52.76 | 1.14 × 10−7 |
| ALDH8A1 | aldehyde dehydrogenase 8 family member A1 | 41.51 | 2.77 × 10−4 |
| FOS | Fos proto-oncogene, AP-1 transcription factor subunit | 30.14 | 0.00 × 100 |
| LRIT3 | leucine rich repeat, Ig-like and transmembrane domains 3 | 26.41 | 5.34 × 10−13 |
| MAB21L1 | mab-21 like 1 | 23.95 | 3.27 × 10−3 |
| KLB | klotho beta | 22.63 | 1.07 × 10−6 |
| TRIM72 | tripartite motif containing 72 | 22.12 | 4.56 × 10−3 |
| AREG | amphiregulin | 21.64 | 0.00 × 100 |
| HAS1 | hyaluronan synthase 1 | 20.11 | 6.67 × 10−3 |
| ZFAND2A | zinc finger AN1-type containing 2A | 16.36 | 0.00 × 100 |
| CEL | carboxyl ester lipase | 15.64 | 2.00 × 10−2 |
| PDE8A | phosphodiesterase 8A | 15.04 | 2.00 × 10−2 |
| DNAJB1 | DnaJ heat shock protein family (Hsp40) member B1 | 11.82 | 0.00 × 100 |
| LRRC4 | leucine rich repeat containing 4 | 10.84 | 5.73 × 10−3 |
| NLGN3 | neuroligin 3 | 10.25 | 8.92 × 10−4 |
| HTR2B | 5-hydroxytryptamine receptor 2B | 9.09 | 1.00 × 10−2 |
| RIN2 | Ras and Rab interactor 2 | −29.93 | 7.82 × 10−7 |
| CXCL2 | C-X-C motif chemokine ligand 2 | −8.46 | 0.00 × 100 |
| BCLAF1 | BCL2 associated transcription factor 1 | −7.79 | 2.97 × 10−5 |
| DDAH2 | dimethylarginine dimethylaminohydrolase 2 | −5.82 | 2.00 × 10−2 |
| TLR6 | toll like receptor 6 | −4.96 | 1.62 × 10−6 |
| Gm11214 | glyceraldehyde-3-phosphate dehydrogenase pseudogene | −4.70 | 3.00 × 10−2 |
| PTP4A1 | protein tyrosine phosphatase 4A1 | −4.37 | 1.19 × 10−14 |
| HPS6 | HPS6 biogenesis of lysosomal organelles complex 2 subunit 3 | −3.98 | 0.00 × 100 |
| DDX28 | DEAD-box helicase 28 | −3.94 | 0.00 × 100 |
| OSBPL7 | oxysterol binding protein like 7 | −3.85 | 0.00 × 100 |
| HOXD4 | homeobox D4 | −3.83 | 1.22 × 10−5 |
| HOXA1 | homeobox A1 | −3.55 | 7.93 × 10−3 |
| ABTB1 | ankyrin repeat and BTB domain containing 1 | −3.53 | 1.38 × 10−12 |
| LFNG | LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | −3.45 | 0.00 × 100 |
| NFKBIA | NFKB inhibitor alpha | −3.45 | 0.00 × 100 |
| CSF3 | colony stimulating factor 3 | −3.44 | 6.38 × 10−3 |
| AMT | aminomethyltransferase | −3.39 | 4.60 × 10−14 |
| Iigp1 | interferon inducible GTPase 1 | −3.38 | 6.35 × 10−3 |
| MYORG | myogenesis regulating glycosidase (putative) | −3.37 | 6.90 × 10−8 |
| EPHB3 | EPH receptor B3 | −3.32 | 2.74 × 10−7 |
* The overall number of significantly decreasing genes in the case of sample pair 40 °C, 1 h compared to 37 °C was only 9.
Figure 4RNA sequencing data reveal distinct stress transcriptome upon different stress conditions. (a) RNAseq samples of CHO cells distinguished by principal component analysis. (b) Heatmap representation of hierarchical clustering. (c) Expression of total of 920 genes had significantly changed by different doses of mild (40 °C, 1 h and 6 h) and moderate (42.5 °C, 1 h) heat treatments in pairwise comparison to controls (37 °C)—shown in Venn diagram.
Figure 5The most significantly enriched canonical pathways (−log(B-H p-value) > 2.0) in heat-treated CHO cells derived from Ingenuity Pathway Analysis (IPA).
Figure 6Heat-induced lipidomic changes. CHO cells were left untreated or subjected to 40 °C for 1 or 6 h or 42.5 °C for 1 h. (a) Partial least squares discriminant analysis score plots of lipidomic dataset based on relative concentration values. Circles display 95% confidence regions. The model was validated by a 2000-time permutation test (p = 0.0015). (b) Venn diagram displaying the number of statistically different components.
Selected, significantly changing membrane lipid species.
| Lipid Species | 37 °C | 40 °C, 1 h | 40 °C, 6 h | 42.5 °C, 1 h |
|---|---|---|---|---|
| Glycerophospholipids | ||||
| PC(32:1) | 2.568 ± 0.023 | 2.564 ± 0.025 | 2.680 ± 0.016 * | 2.537 ± 0.040 |
| PC(32:0) | 2.050 ± 0.061 | 2.264 ± 0.066 | 2.239 ± 0.036 * | 2.391 ± 0.053 * |
| PC(34:2) | 2.949 ± 0.029 | 2.936 ± 0.030 | 3.115 ± 0.025 * | 2.842 ± 0.044 |
| PC(34:1) | 12.691 ± 0.102 | 12.957 ± 0.117 | 13.844 ± 0.144 * | 12.924 ± 0.145 |
| PC(36:4) | 2.894 ± 0.060 | 2.847 ± 0.075 | 2.487 ± 0.031 * | 2.664 ± 0.054 * |
| PC(36:1) | 1.942 ± 0.028 | 1.970 ± 0.023 | 2.172 ± 0.051 * | 1.892 ± 0.028 |
| PC(38:6) | 1.468 ± 0.017 | 1.460 ± 0.037 | 1.322 ± 0.035 * | 1.256 ± 0.024 * |
| PC(38:5) | 2.438 ± 0.046 | 2.434 ± 0.075 | 1.953 ± 0.050 * | 2.231 ± 0.052 * |
| PC(38:4) | 1.657 ± 0.042 | 1.685 ± 0.057 | 1.359 ± 0.042 * | 1.588 ± 0.045 |
| PC(40:6) | 0.778 ± 0.009 | 0.770 ± 0.018 | 0.688 ± 0.022 * | 0.651 ± 0.013 * |
| PC(O-32:0) | 0.188 ± 0.007 | 0.202 ± 0.012 | 0.288 ± 0.013 * | 0.212 ± 0.010 |
| PC(O-34:1) | 1.755 ± 0.062 | 1.819 ± 0.056 | 2.172 ± 0.058 * | 1.941 ± 0.053 |
| PC(O-36:1) | 0.229 ± 0.016 | 0.236 ± 0.017 | 0.329 ± 0.016 * | 0.231 ± 0.015 |
| PC(O-38:5) | 1.174 ± 0.023 | 1.219 ± 0.020 | 1.069 ± 0.026 * | 1.298 ± 0.020 * |
| PE(34:1) | 0.730 ± 0.011 | 0.728 ± 0.018 | 0.805 ± 0.019 * | 0.671 ± 0.016 * |
| PE(38:6) | 0.406 ± 0.014 | 0.380 ± 0.006 | 0.339 ± 0.006 * | 0.355 ± 0.009 * |
| PE(38:5) | 0.714 ± 0.028 | 0.659 ± 0.013 | 0.571 ± 0.013 * | 0.630 ± 0.017 * |
| PE(38:4) | 1.221 ± 0.051 | 1.159 ± 0.032 | 1.007 ± 0.023 * | 1.111 ± 0.036 |
| PE(P-38:5) | 0.988 ± 0.027 | 0.920 ± 0.014 | 0.879 ± 0.016 * | 0.985 ± 0.026 |
| PE(P-40:7) | 0.434 ± 0.019 | 0.408 ± 0.009 | 0.343 ± 0.009 * | 0.456 ± 0.008 |
| PE(P-40:6) | 0.698 ± 0.015 | 0.683 ± 0.009 | 0.612 ± 0.011 * | 0.728 ± 0.014 |
| PE(P-40:5) | 0.583 ± 0.020 | 0.568 ± 0.010 | 0.493 ± 0.013 * | 0.625 ± 0.014 |
| PI(34:1) | 0.313 ± 0.012 | 0.336 ± 0.019 | 0.520 ± 0.026 * | 0.317 ± 0.013 |
| PI(36:1) | 0.268 ± 0.008 | 0.282 ± 0.012 | 0.428 ± 0.015 * | 0.349 ± 0.010 * |
| PI(38:5) | 0.485 ± 0.012 | 0.476 ± 0.006 | 0.424 ± 0.007 * | 0.438 ± 0.007 * |
| PI(38:4) | 4.089 ± 0.120 | 4.040 ± 0.078 | 3.612 ± 0.076 * | 4.189 ± 0.088 |
| PS(38:4) | 0.196 ± 0.004 | 0.177 ± 0.007 | 0.138 ± 0.003 * | 0.218 ± 0.006 * |
| PG(40:7) | 0.164 ± 0.006 | 0.155 ± 0.009 | 0.129 ± 0.007 * | 0.156 ± 0.012 |
| PG(44:12) | 0.056 ± 0.003 | 0.050 ± 0.002 | 0.024 ± 0.002 * | 0.045 ± 0.004 |
| PG(44:11) | 0.020 ± 0.002 | 0.018 ± 0.001 | 0.005 ± 0.001 * | 0.018 ± 0.002 |
| CL(72:6) | 0.196 ± 0.008 | 0.181 ± 0.003 | 0.165 ± 0.003 * | 0.186 ± 0.004 |
| CL(72:5) | 0.133 ± 0.004 | 0.124 ± 0.004 | 0.113 ± 0.002 * | 0.129 ± 0.004 |
|
| ||||
| LPC(16:0) | 0.085 ± 0.007 | 0.091 ± 0.010 | 0.118 ± 0.011 * | 0.083 ± 0.008 |
| LPC(18:0) | 0.029 ± 0.003 | 0.034 ± 0.004 | 0.042 ± 0.002 * | 0.029 ± 0.002 |
| LPI(16:0) | 0.010 ± 0.000 | 0.012 ± 0.001 * | 0.022 ± 0.001 * | 0.013 ± 0.001 |
| LPI(18:0) | 0.062 ± 0.002 | 0.074 ± 0.003 * | 0.123 ± 0.005 * | 0.101 ± 0.010 * |
|
| ||||
| SM(34:1:2) | 6.201 ± 0.069 | 6.260 ± 0.077 | 6.305 ± 0.079 | 6.759 ± 0.071 * |
| SM(34:0:2) | 0.082 ± 0.004 | 0.087 ± 0.003 | 0.074 ± 0.005 | 0.099 ± 0.004 * |
| Cer(34:1:2) | 0.097 ± 0.004 | 0.090 ± 0.002 | 0.105 ± 0.002 | 0.142 ± 0.003 * |
| Cer(42:2:2) | 0.065 ± 0.002 | 0.073 ± 0.002 * | 0.090 ± 0.002 * | 0.090 ± 0.002 * |
| HexCer(34:1:2) | 0.155 ± 0.006 | 0.156 ± 0.006 | 0.145 ± 0.004 | 0.203 ± 0.005 * |
| HexCer(42:2:2) | 0.049 ± 0.002 | 0.049 ± 0.002 | 0.045 ± 0.001 | 0.061 ± 0.002 * |
Data are presented as mol% of membrane lipids and are expressed as mean ± SEM, n = 8. Student’s t-tests were performed for pairwise multiple comparisons; significance was accepted for p < 0.025 (*) corresponding to a false discovery rate q < 0.05. PC and PC-O, diacyl and alkyl-acyl phosphatidylcholine; PE and PE-P, diacyl and alkenyl-acyl phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; PG, phosphatidylglycerol; CL, cardiolipin; LPC, LPI, the corresponding lysolipids; SM, sphingomyelin; Cer, ceramide; HexCer, hexosylceramide.
Figure 7Heat-induced lipidomic changes. CHO cells were left untreated or subjected to 40 °C for 1 or 6 h or 42.5 °C for 1 h. (a–d) Changes in the relative concentration (a) of disaturated and monounsaturated membrane lipid species (db ≤ 1), (b) in polyunsaturated components (db ≥ 4), (c) in lysolipid species and (d) in sphingolipids. Data are expressed as mean ± SEM, n = 8; * denotes p < 0.025 compared to the untreated control. db, number of double bonds; PC, phosphatidylcholine; PI, phosphatidylinositol; LPC and LPI, the corresponding lyso species; Cer, ceramide; SM, sphingomyelin; HexCer, hexosylceramide.